Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Case of nivolumab-induced sclerosing cholangitis: lessons from long-term follow-up
View through CrossRef
Nivolumab is an immune checkpoint inhibitor used to treat multiple solid-organ malignancies. While many of its immune-related adverse events are well established, nivolumab-induced sclerosing cholangitis remains poorly characterised, with no defined diagnostic criteria. Moreover, data regarding long-term outcomes are particularly lacking. We present a biopsy-proven case of nivolumab-induced sclerosing cholangitis, which uniquely captures 18 months of follow-up post-treatment. Our case highlights key features of intrahepatic subtype sclerosing cholangitis and suggests durable response to corticosteroid therapy.
Title: Case of nivolumab-induced sclerosing cholangitis: lessons from long-term follow-up
Description:
Nivolumab is an immune checkpoint inhibitor used to treat multiple solid-organ malignancies.
While many of its immune-related adverse events are well established, nivolumab-induced sclerosing cholangitis remains poorly characterised, with no defined diagnostic criteria.
Moreover, data regarding long-term outcomes are particularly lacking.
We present a biopsy-proven case of nivolumab-induced sclerosing cholangitis, which uniquely captures 18 months of follow-up post-treatment.
Our case highlights key features of intrahepatic subtype sclerosing cholangitis and suggests durable response to corticosteroid therapy.
Related Results
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct
Introduction
Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
Clinical Criteria and Operative Complications of Complicated Cholangitis
Clinical Criteria and Operative Complications of Complicated Cholangitis
Introduction: Complicated cholangitis is a severe bacterial infection of the bile ducts that often occurs in patients with biliary obstruction. The condition is characterized by a ...
Association between antibiotic exposure and survival in patients with hepatocellular carcinoma treated with nivolumab.
Association between antibiotic exposure and survival in patients with hepatocellular carcinoma treated with nivolumab.
e16186 Background: Nivolumab, an immune checkpoint inhibitor, has improved the outcomes of patients with hepatocellular carcinoma (HCC). It is approved for HCC patients previously...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract
Introduction
Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Nivolumab induced cutaneous reactions in a patient with lung cancer– A case study
Nivolumab induced cutaneous reactions in a patient with lung cancer– A case study
Nivolumab, a PDL1 antagonist is an immunotherapeutic agent that is effectively used for the second-line treatment of advanced or metastatic lung carcinoma. Although Nivolumab impro...
Nivolumab monotherapy or in combination with ipilimumab for metastatic melanoma: systematic review and meta-analysis of randomized-controlled trials
Nivolumab monotherapy or in combination with ipilimumab for metastatic melanoma: systematic review and meta-analysis of randomized-controlled trials
Nivolumab, a completely human programmed death-1 inhibitor antibody, was first approved by the Food and Drug Administration for patients with advanced malignant melanoma resistant ...
IgG4-Related Sclerosing Cholangitis Mimicking Cholangiocarcinoma
IgG4-Related Sclerosing Cholangitis Mimicking Cholangiocarcinoma
IgG4-related sclerosing cholangitis (IgG4-SC) is a relatively newly identified disease that is frequently associated with autoimmune pancreatitis. The differential diagnosis betwee...
Evaluation of cardiac adverse events with nivolumab using a Japanese real-world database
Evaluation of cardiac adverse events with nivolumab using a Japanese real-world database
Abstract
The present study aimed to determine the risk of nivolumab-induced cardiac adverse events (AEs), time to onset, incidence rates, and post hoc outcomes using the Ja...